Sabine Hoves

6PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 18, 2022
Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.

Aleksandar Murgaski, Máté Kiss, Helena Van Damme

|Jun 17, 2021
Macrophage depletion induces edema through release of matrix-degrading proteases and proteoglycan deposition.

Stefan Bissinger, Carina Hage, Vinona Wagner

|Jan 01, 2020
Optimized antiangiogenic reprogramming of the tumor microenvironment potentiates CD40 immunotherapy.

Abhishek S Kashyap, Martina Schmittnaegel, Nicolò Rigamonti

|Sep 14, 2018
Chemotherapy Combines Effectively with Anti-PD-L1 Treatment and Can Augment Antitumor Responses.

Rafael Cubas, Marina Moskalenko, Jeanne Cheung

|Apr 13, 2018
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade.

Natalie J Neubert, Martina Schmittnaegel, Natacha Bordry

Pageof 1